NCT02947776 (SUPERB) is a NA clinical trial of PEER in Stroke, sponsored by City, University of London.

Who is sponsoring NCT02947776?

NCT02947776 is sponsored by City, University of London.

What drugs are being tested in NCT02947776?

Interventions in NCT02947776: PEER, USUAL.

What condition does NCT02947776 study?

NCT02947776 studies Stroke, Aphasia.

Is NCT02947776 still recruiting?

NCT02947776 is currently completed. Last updated 22 July 2020.

Last reviewed 2020-07-22 · How we verify

NCT02947776: SUPERB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adjustment With Aphasia After Stroke: SUPERB

Completed NA Last updated 22 July 2020

What this trial tests

NA trial testing PEER in Stroke in 62 participants. Completed in 20 August 2019.

Timeline

25 May 2017

Primary endpoint
20 August 2019

20 August 2019

Quick facts

Lead sponsor	City, University of London
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	62
Start date	25 May 2017
Primary completion	20 August 2019
Estimated completion	20 August 2019
Sites	5 locations across United Kingdom

Drugs / interventions tested

PEER
USUAL

Conditions studied

Stroke — all drugs for Stroke →
Aphasia — all drugs for Aphasia →

Sponsor

City, University of London

Who can join

18 and older, any sex, with Stroke or Aphasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aims: This exploratory trial will: 1. Explore the feasibility of a definitive/phase III RCT on clinical and cost-effectiveness of peer-befriending for people with aphasia post-stroke. 2. Investigate psychological and social wellbeing outcomes of participants, significant others, and peer befrienders. 3. Explore the feasibility of a full economic evaluation of usual care + peer befriending versus usual care control. Design: Single blind, mixed methods, parallel group phase II RCT comparing usual care + peer-befriending vs. usual care, starting at discharge from hospital. The study will deliver on four work packages: development phase; RCT; qualitative study; economic evaluation. Participants (n=60) will be assessed three times up to 10 months post-randomisation. Outcome measures: Feasibility: feasibility of recruitment to definitive trial (proportion screened who meet criteria; proportion who consent; rate of consent); participant, significant other, peer befriender views on acceptability of procedures (qualitative study); number of missing/incomplete data on outcome measures; attrition rate at follow-up; potential value of conducting main trial using value of information analysis (economic evaluation); description of usual care; treatment fidelity of peer-befriending. Patient-reported outcomes will include mood, wellbeing, communication and social participation. Benefits: Peer befriending may help avert some of the serious psychological consequences of stroke, and prevent the need for more complex and costly psychological therapies.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Supporting wellbeing through peer-befriending (SUPERB) for people with aphasia: A feasibility randomised controlled trial.
Hilari K, Behn N, James K, Northcott S, et al · · 2021 · cited 29× · PMID 33624514 · DOI 10.1177/0269215521995671
Adjustment with aphasia after stroke: study protocol for a pilot feasibility randomised controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB).
Hilari K, Behn N, Marshall J, Simpson A, et al · · 2019 · cited 16× · PMID 30693094 · DOI 10.1186/s40814-019-0397-6
Pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke.
Allida SM, Hsieh CF, Cox KL, Patel K, et al · · 2023 · cited 11× · PMID 37417452 · DOI 10.1002/14651858.cd003437.pub5
"For them and for me": a qualitative exploration of peer befrienders' experiences supporting people with aphasia in the SUPERB feasibility trial.
Northcott S, Behn N, Monnelly K, Moss B, et al · · 2022 · cited 8× · PMID 34027757 · DOI 10.1080/09638288.2021.1922520
"Loneliness can also kill:" a qualitative exploration of outcomes and experiences of the SUPERB peer-befriending scheme for people with aphasia and their significant others.
Moss B, Behn N, Northcott S, Monnelly K, et al · · 2022 · cited 7× · PMID 34086521 · DOI 10.1080/09638288.2021.1922519
SUpporting wellbeing through PEeR-Befriending (SUPERB) feasibility trial: fidelity of peer-befriending for people with aphasia.
Behn N, Moss B, McVicker S, Roper A, et al · · 2021 · cited 3× · PMID 34341046 · DOI 10.1136/bmjopen-2020-047994
A pilot economic evaluation of a feasibility trial for SUpporting wellbeing through PEeR-Befriending (SUPERB) for post-stroke aphasia.
Flood C, Behn N, Marshall J, Simpson A, et al · · 2022 · cited 2× · PMID 35108114 · DOI 10.1177/02692155211063554

Verify or expand the search:

Other trials of PEER

Trials testing the same drug.

NCT06646757 — Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability · NA · completed

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other City, University of London trials

Trials by the same sponsor.

NCT06310681 — Pilot Testing of a Co-adapted Group Programme for Parents/Carers of Children With Complex Neurodisability · NA · completed
NCT06703827 — Effects of Online Metacognitive Training Group on Distressing Beliefs · NA · recruiting
NCT06241976 — Diabetes Risk in London and Its Association with Vitamin D by Ethnic Group (DELVE) · NA · completed
NCT07158762 — Blood Glucose Levels After Bread Consumption Between Participants With Normal Weight and Overweight/Obesity · NA · completed
NCT05847023 — Proof-of-concept Study of LUNA Intervention in Aphasia · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02947776 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by City, University of London
Last refreshed: 22 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02947776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing